Carl W. Rausch
Corporate Officer/Principal chez World Technology East II Ltd.
Profil
Carl W.
Rausch is currently the Managing Principal Partner at World Technology East II Ltd.
He was previously the CEO, CFO, Director & Chief Accounting Officer at Boston Therapeutics, Inc. from 2016 to 2019.
Prior to that, he was the Vice Chairman & Chief Technology Officer at Biopure Corp.
from 2002 to 2005.
He also held a Vice President position at EMD Millipore Corp.
and was a Principal at Medical Technology Associates II, Inc. Mr. Rausch has a graduate degree from Massachusetts Institute of Technology and undergraduate and graduate degrees from Tufts University.
Postes actifs de Carl W. Rausch
| Sociétés | Poste | Début |
|---|---|---|
| World Technology East II Ltd. | Corporate Officer/Principal | 01/01/2014 |
Anciens postes connus de Carl W. Rausch
| Sociétés | Poste | Fin |
|---|---|---|
| NANOMIX CORPORATION | Directeur Général | 12/12/2019 |
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Président | 01/01/2002 |
Medical Technology Associates II, Inc.
 Medical Technology Associates II, Inc. Miscellaneous Commercial ServicesCommercial Services Medical Technology Associates II, Inc. develops novel biopharmaceuticals through its proprietary ALTAPURE™ technology. The company was founded on August 8, 2016 and is headquartered in Durham, NH. | Corporate Officer/Principal | - |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Corporate Officer/Principal | - |
Formation de Carl W. Rausch
| Massachusetts Institute of Technology | Graduate Degree |
| Tufts University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
| World Technology East II Ltd. | |
Medical Technology Associates II, Inc.
Medical Technology Associates II, Inc. Miscellaneous Commercial ServicesCommercial Services Medical Technology Associates II, Inc. develops novel biopharmaceuticals through its proprietary ALTAPURE™ technology. The company was founded on August 8, 2016 and is headquartered in Durham, NH. | Commercial Services |
